519 related articles for article (PubMed ID: 27847121)
1. Outcomes following routine antithrombin III replacement during neonatal extracorporeal membrane oxygenation.
Stansfield BK; Wise L; Ham PB; Patel P; Parman M; Jin C; Mathur S; Harshfield G; Bhatia J
J Pediatr Surg; 2017 Apr; 52(4):609-613. PubMed ID: 27847121
[TBL] [Abstract][Full Text] [Related]
2. Antithrombin III supplementation during neonatal and pediatric extracorporeal membrane oxygenation.
Meshulami N; Green R; Kaushik S
Artif Organs; 2023 Dec; 47(12):1848-1853. PubMed ID: 37658611
[TBL] [Abstract][Full Text] [Related]
3. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
Krueger K; Schmutz A; Zieger B; Kalbhenn J
Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
[TBL] [Abstract][Full Text] [Related]
4. The Use of Recombinant Antithrombin III in Pediatric and Neonatal ECMO Patients.
Todd Tzanetos DR; Myers J; Wells T; Stewart D; Fanning JJ; Sullivan JE
ASAIO J; 2017; 63(1):93-98. PubMed ID: 27861430
[TBL] [Abstract][Full Text] [Related]
5. Impact of Anticoagulation and Circuit Technology on Complications During Extracorporeal Membrane Oxygenation.
Niebler RA; Parker H; Hoffman GM
ASAIO J; 2019; 65(3):270-276. PubMed ID: 29746314
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin replacement during extracorporeal membrane oxygenation.
Niebler RA; Christensen M; Berens R; Wellner H; Mikhailov T; Tweddell JS
Artif Organs; 2011 Nov; 35(11):1024-8. PubMed ID: 22097980
[TBL] [Abstract][Full Text] [Related]
7. Retrospective evaluation of antithrombin III supplementation in neonates and infants receiving enoxaparin for treatment of thrombosis.
Corder A; Held K; Oschman A
Pediatr Blood Cancer; 2014 Jun; 61(6):1063-7. PubMed ID: 24375987
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal membrane oxygenation-hemostatic complications.
Murphy DA; Hockings LE; Andrews RK; Aubron C; Gardiner EE; Pellegrino VA; Davis AK
Transfus Med Rev; 2015 Apr; 29(2):90-101. PubMed ID: 25595476
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation Practices during Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure. A Systematic Review.
Sklar MC; Sy E; Lequier L; Fan E; Kanji HD
Ann Am Thorac Soc; 2016 Dec; 13(12):2242-2250. PubMed ID: 27690525
[TBL] [Abstract][Full Text] [Related]
10. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
11. Antithrombin III infusion improves anticoagulation in congenital diaphragmatic hernia patients on extracorporeal membrane oxygenation.
Perry T; Henry B; Cooper DS; Keswani SG; Burton KS; Lim FY; Chernoguz A; Frischer JS
Perfusion; 2023 Apr; 38(3):507-514. PubMed ID: 34939461
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a pharmacy managed heparin protocol for extracorporeal membrane oxygenation patients.
Fitousis K; Klasek R; Mason PE; Masud F
Perfusion; 2017 Apr; 32(3):238-244. PubMed ID: 27837164
[TBL] [Abstract][Full Text] [Related]
13. Anti-xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation.
O'Meara LC; Alten JA; Goldberg KG; Timpa JG; Phillips J; Laney D; Borasino S
ASAIO J; 2015; 61(3):339-44. PubMed ID: 25710768
[TBL] [Abstract][Full Text] [Related]
14. Bleeding, Thrombosis, and Transfusion With Two Heparin Anticoagulation Protocols in Venoarterial ECMO Patients.
Mazzeffi MA; Tanaka K; Roberts A; Rector R; Menaker J; Kon Z; Deatrick KB; Kaczorowski D; Griffith B; Herr D
J Cardiothorac Vasc Anesth; 2019 May; 33(5):1216-1220. PubMed ID: 30181084
[TBL] [Abstract][Full Text] [Related]
15. Antithrombin supplementation in adult patients receiving extracorporeal membrane oxygenation.
Morrisette MJ; Zomp-Wiebe A; Bidwell KL; Dunn SP; Gelvin MG; Money DT; Palkimas S
Perfusion; 2020 Jan; 35(1):66-72. PubMed ID: 31213179
[TBL] [Abstract][Full Text] [Related]
16. Hematological abnormalities in neonatal patients treated with extracorporeal membrane oxygenation (ECMO).
Zavadil DP; Stammers AH; Willett LD; Deptula JJ; Christensen KA; Sydzyik RT
J Extra Corpor Technol; 1998 Jun; 30(2):83-90. PubMed ID: 10182118
[TBL] [Abstract][Full Text] [Related]
17. Use of Thromboelastography to Predict Thrombotic Complications in Pediatric and Neonatal Extracorporeal Membranous Oxygenation.
Henderson N; Sullivan JE; Myers J; Wells T; Calhoun A; Berkenbosch J; Tzanetos DT
J Extra Corpor Technol; 2018 Sep; 50(3):149-154. PubMed ID: 30250340
[TBL] [Abstract][Full Text] [Related]
18. The Impact and Statistical Analysis of a Multifaceted Anticoagulation Strategy in Children Supported on ECMO: Performance and Pitfalls.
Kessel AD; Kline M; Zinger M; McLaughlin D; Silver P; Sweberg TM
J Intensive Care Med; 2017 Jan; 32(1):59-67. PubMed ID: 26319579
[TBL] [Abstract][Full Text] [Related]
19. The use of an extracorporeal membrane oxygenation anticoagulation laboratory protocol is associated with decreased blood product use, decreased hemorrhagic complications, and increased circuit life.
Northrop MS; Sidonio RF; Phillips SE; Smith AH; Daphne HC; Pietsch JB; Bridges BC
Pediatr Crit Care Med; 2015 Jan; 16(1):66-74. PubMed ID: 25319630
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated with Bleeding and Thrombosis in Children Receiving Extracorporeal Membrane Oxygenation.
Dalton HJ; Reeder R; Garcia-Filion P; Holubkov R; Berg RA; Zuppa A; Moler FW; Shanley T; Pollack MM; Newth C; Berger J; Wessel D; Carcillo J; Bell M; Heidemann S; Meert KL; Harrison R; Doctor A; Tamburro RF; Dean JM; Jenkins T; Nicholson C;
Am J Respir Crit Care Med; 2017 Sep; 196(6):762-771. PubMed ID: 28328243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
